1.Edwards R. The problem of tobacco smoking. BMJ. 2004. 328(7433):217–9.
Article
2.Korea health statistics 2010. The 5th Korea National Health and Nutrition Examination Survey (KNHANESV–1). Cheongju: Korea Centers for Disease Control and Prevention;2010. [Accessed July 15, 2013].https://knhanes.cdc.go.kr/knhanes/index.do.
3.Song HR., Kim CH. Epidemiology of the smoking–related diseases in Korea. J Korean Acad Fam Med. 2008. 29(8):563–71.
4.Gambaro G., Verlato F., Budakovic A., Casara D., Saladini G., Del Prete D, et al. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol. 1998. 9(4):562–7.
Article
5.Noborisaka Y. Smoking and chronic kidney disease in healthy populations. Nephrourol Mon. 2013. 5(1):655–67.
6.Locatelli F., Vecchio LD., Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant. 2002. 17(Suppl 11):2–7.
Article
7.Stevens PE., Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013. 158(11):825–30.
Article
8.Jafar TH., Chaturvedi N., Hatcher J., Levey AS. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo–Asian population. Nephrol Dial Transplant. 2007. 22(8):2194–200.
Article
9.Tkácová R., Tkác I., Podracký J., Moscovic P., Roland R., Hildebrand T. Spirometric alterations in patients with reduced renal function. Wien Klin Wochenschr. 1993. 105(1):21–4.
10.Yoon JH., Won JU., Ahn YS., Roh J. Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and Nutrition Examination Survey. PLoS One. 2014. 9(4):e94125.
Article
11.Casanova C., de Torres JP., Navarro J., Aguirre–Jaíme A., Toledo P., Cordoba E, et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010. 182(8):): 1004–10.
Article
12.Miller MR., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005. 26(2):319–38.
13.Choi JK., Paek D., Lee JO. Normal predictive values of Spirometry in Korean population. Tuberc Respir Dis. 2005. 58(3):230–42.
Article
14.Levey AS., Bosch JP., Lewis JB., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999. 130(6):461–70.
Article
15.National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002. 39(2 Suppl 1):): S1–266.
16.Anand S., Khanam MA., Saquib J., Saquib N., Ahmed T., Alam DS, et al. High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross–sectional study. Global Health. 2014. 10:9.
Article
17.Pinto–Sietsma SJ., Mulder J., Janssen WM., Hillege HL., de Zeeuw D., de Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med. 2000. 133:585–91.
Article
18.Maeda I., Hayashi T., Sato KK., Koh H., Harita N., Nakamura Y, et al. Cigarette smoking and the association with glomerular hy-perfiltration and proteinuria in healthy middle–aged men. Clin J Am Soc Nephrol. 2011. 6(10):2462–9.
Article
19.Shankar A., Klein R., Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006. 164(3):263–71.
Article
20.Yamagata K., Ishida K., Sairenchi T., Takahashi H., Ohba S., Shiigai T, et al. Risk factors for chronic kidney disease in a com-munity–based population: a 10–year follow–up study. Kidney Int. 2007. 71(2):159–66.
Article
21.Briganti EM., Branley P., Chadban SJ., Shaw JE., McNeil JJ., Welborn TA, et al. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Am J Kidney Dis. 2002. 40(4):704–12.
Article
22.Halimi JM., Giraudeau B., Vol S., Cacès E., Nivet H., Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 2000. 58(3):1285–92.
Article
23.Noborisaka Y., Honda R., Ishizaki M., Nakata M., Yamada Y. Alcohol and cigarette consumption, renal function and blood pressure in middle–aged healthy men. J Hum Hypertens. 2007. 21(12):966–8.
Article
24.Yoon HJ., Park M., Yoon H., Son KY., Cho B., Kim S. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res. 2009. 32(3):214–9.
Article
25.Zhang L., Zhang P., Wang F., Zuo L., Zhou Y., Shi Y, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008. 51(3):373–84.
Article
26.Bazzano LA., He J., Muntner P., Vupputuri S., Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003. 138(11):891–7.
Article
27.Gan WQ., Man SF., Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest. 2005. 127(2):558–64.
Article
28.Eagan TM., Ueland T., Wagner PD., Hardie JA., Mollnes TE., Damås JK, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010. 35(5):540–8.
Article
29.Arici M., Walls J. End–stage renal disease, atherosclerosis, and cardiovascular mortality: is C–reactive protein the missing link? Kidney Int. 2001. 59(2):407–14.
Article
30.Yanbaeva DG., Dentener MA., Creutzberg EC., Wesseling G., Wouters EF. Systemic effects of smoking. Chest. 2007. 131(5):1557–66.
Article